Treatment and follow-up
The median follow-up period of the patients was 8 months (range: 1 month-5 years and 9 months). Thirty-three (50.8%) patients continued to follow up in our clinic. Inhaled ipratropium bromide therapy was started for 37 (56.9%) patients and terminated after 6 months in four patients because of clinical improvement yet the others continued to treatment. While 20 (30.8%) patients needed supplemental oxygen therapy after diagnosis of malacia, 10 (15.4%) patients required continuous positive pressure support with invasive MV. Only one patient needed non-invasive MV treatment. Tracheostomy was performed in 10 (15.4%) patients who were underwent invasive MV treatment; of them, two had isolated TM and one had TBM. None of the patients was performed any surgical treatment for malacic airways. Three patients (4.6%) died during follow-up.